DERMATOPHAGOIDES PTERONYSSINUS: 146 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
146
Total FAERS Reports
0
Deaths Reported
7
Hospitalizations
146
As Primary/Secondary Suspect
ALK-Abello, Inc.
Manufacturer
Drug Class: Allergens [CS] · Manufacturer: ALK-Abello, Inc. ·
First Report: 20150318 · Latest Report: 20250718
What Are the Most Common DERMATOPHAGOIDES PTERONYSSINUS Side Effects?
#1 Most Reported
Anaphylactic reaction
29 reports (19.9%)
#2 Most Reported
Urticaria
25 reports (17.1%)
#3 Most Reported
Throat irritation
19 reports (13.0%)
All DERMATOPHAGOIDES PTERONYSSINUS Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Anaphylactic reaction | 29 | 19.9% | 0 | 4 |
| Urticaria | 25 | 17.1% | 0 | 0 |
| Throat irritation | 19 | 13.0% | 0 | 0 |
| Wheezing | 15 | 10.3% | 0 | 0 |
| Injection site reaction | 14 | 9.6% | 0 | 0 |
| Local reaction | 13 | 8.9% | 0 | 2 |
| Cough | 12 | 8.2% | 0 | 1 |
| Dyspnoea | 11 | 7.5% | 0 | 2 |
| Pruritus | 11 | 7.5% | 0 | 0 |
| Chest discomfort | 10 | 6.9% | 0 | 0 |
| Erythema | 9 | 6.2% | 0 | 0 |
| Dizziness | 8 | 5.5% | 0 | 0 |
| False negative investigation result | 8 | 5.5% | 0 | 1 |
| Injection site erythema | 8 | 5.5% | 0 | 1 |
| Throat tightness | 8 | 5.5% | 0 | 0 |
| Eye pruritus | 7 | 4.8% | 0 | 1 |
| Injection site dryness | 6 | 4.1% | 0 | 0 |
| Injection site pain | 6 | 4.1% | 0 | 0 |
| Injection site pruritus | 6 | 4.1% | 0 | 0 |
| Injection site urticaria | 6 | 4.1% | 0 | 1 |
Who Reports DERMATOPHAGOIDES PTERONYSSINUS Side Effects? Age & Gender Data
Gender: 65.7% female, 34.3% male. Average age: 37.3 years. Most reports from: US. View detailed demographics →
Is DERMATOPHAGOIDES PTERONYSSINUS Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2015 | 5 | 0 | 0 |
| 2016 | 27 | 0 | 0 |
| 2017 | 15 | 0 | 0 |
| 2018 | 7 | 0 | 0 |
| 2019 | 5 | 0 | 0 |
| 2020 | 6 | 0 | 1 |
| 2021 | 12 | 0 | 1 |
| 2022 | 25 | 0 | 3 |
| 2023 | 12 | 0 | 1 |
| 2024 | 8 | 0 | 1 |
| 2025 | 3 | 0 | 0 |
What Is DERMATOPHAGOIDES PTERONYSSINUS Used For?
| Indication | Reports |
|---|---|
| Product used for unknown indication | 30 |
| Skin test | 10 |
| Rhinitis allergic | 9 |
DERMATOPHAGOIDES PTERONYSSINUS vs Alternatives: Which Is Safer?
DERMATOPHAGOIDES PTERONYSSINUS vs DESFLURANE
DERMATOPHAGOIDES PTERONYSSINUS vs DESIPRAMINE
DERMATOPHAGOIDES PTERONYSSINUS vs DESLORATADINE
DERMATOPHAGOIDES PTERONYSSINUS vs DESMOPRESSIN
DERMATOPHAGOIDES PTERONYSSINUS vs DESOGESTREL
DERMATOPHAGOIDES PTERONYSSINUS vs DESOGESTREL\ETHINYL ESTRADIOL
DERMATOPHAGOIDES PTERONYSSINUS vs DESONIDE
DERMATOPHAGOIDES PTERONYSSINUS vs DESOXIMETASONE
DERMATOPHAGOIDES PTERONYSSINUS vs DESVENLAFAXINE
DERMATOPHAGOIDES PTERONYSSINUS vs DETROL
Other Drugs in Same Class: Allergens [CS]
Official FDA Label for DERMATOPHAGOIDES PTERONYSSINUS
Official prescribing information from the FDA-approved drug label.